United States · Investor

Excel Venture Management

Last cheque observed Jan 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Email

QuietVC firm

SeedSeries ASeries BE-healthTelehealthConnected-health

Cheques on record
0%of best year0cheques in 12 months, 32 on record
Since the last cheque2852days00hrs00min00sec
Median round$10MRounds led0 of 32Sole investor2 roundsExits1 from the portfolioMostly inUnited States, 97%
Pitch Excel Venture Management

Excel Venture Management highlights

  1. 01

    32 rounds on record

  2. 02

    Mostly Series B and Series A: 58% of its rounds

  3. 03

    Sole investor in 2 rounds, median $4.7M

  4. 04

    1 exits from the portfolio

What they do

Excel Venture Management builds companies that apply transformative life science technologies to solve problems in healthcare and beyond.From their own website
Type
VC firm (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries ASeries BGrowth
Sectors
E-healthTelehealthConnected-health
Based in
Boston, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first32 appearances

  1. 2019

    1 round

  2. Jan
    NeosensorySeries A · US · FinSMEs$10MWith 2 others
  3. 2015

    5 rounds

  4. Aug
    InfoBionicSeries B · US$8.0MWith 2 others
  5. May
    ClearDATASeries C · US$25MWith 5 others
  6. Apr
    Ayogo HealthSeries A · CA$2.5MWith 2 others
  7. Feb
    AventuraSeries C · US$14MWith 4 others
  8. Jan
    QstreamSeries A · US$4.0MWith 2 others
  9. 2014

    3 rounds

  10. Dec
    ZipongoSeries A · US$5.0MWith 2 others
  11. Oct
    Aileron TherapeuticsSeries E · US$33MWith 6 others
  12. Jul
    Molecular TemplatesVenture · US$7.0MWith 1 other
  13. 2013

    7 rounds

  14. Nov
    Aileron TherapeuticsSeries E · US · finsmes.com$30MWith 5 others
  15. Nov
    ShapeUpSeries B · US · shapeup.com$5.0MWith 1 other
  16. Oct
    PathogenetixSeries C · US · finsmes.com$10MWith 2 others
  17. Oct
    Molecular TemplatesSeries C · US · bioportfolio.com$8.5MWith 1 other
  18. Sept
    AventuraSeries B · US · finsmes.com$4.3MWith 5 others
  19. Aug
    ClearDATASeries B · US · techcrunch.com$7.0MWith 1 other
  20. Jan
    Aileron TherapeuticsSeries D · US · finsmes.com$12MWith 5 others
  21. 2012

    2 rounds

  22. Nov
    Activate NetworksSeries B · US · freshnews.com$10MWith 1 other
  23. Sept
    IlluminOss MedicalSeries C · US · marketwire.com$28MWith 8 others
  24. 2011

    7 rounds

  25. Nov
    PathogenetixSeries B · US · masshightech.com$7.5MWith 3 others
  26. Sept
    AventuraSeries A · US · finsmes.com$13MWith 2 others
  27. Aug
    Cleveland HeartLabSeries B · US · finsmes.com$18MWith 1 other
  28. Aug
    PathogenetixSeries B · US · pathogenetix.com$4.0MWith 2 others
  29. Jul
    nanoMRSeries B · US · nanomr.com$13MWith 3 others
  30. Jul
    Springleaf TherapeuticsSeries B · US · sec.gov$19MWith 1 other
  31. Feb
    Catch.comSeries A · US · xconomy.com$7.0MSole investor
  32. 2010

    5 rounds

  33. Sept
    Lantos TechnologiesSeries A · US · freshnews.com$1.6MWith 2 others
  34. Aug
    ShapeUpSeries A · US · deals.venturebeat.com$5.0MWith 1 other
  35. Jun
    Catch.comSeed · US · venturebeat.com$2.3MSole investor
  36. Jun
    Tetraphase PharmaceuticalsSeries C · US · fiercebiotech.com$45MWith 7 others
  37. Mar
    Saladax BiomedicalSeries C · US · onbiovc.com$8.4MWith 4 others
  38. 2009

    2 rounds

  39. Sept
    MedVentiveSeries C · US · onbiovc.com$7.2MWith 3 others
  40. Jun
    Aileron TherapeuticsSeries D · US · zibb.com$40MWith 6 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration2 named

FBFrederick BlumeManaging DirectoriForm ADV
JEJuan EnriquezManaging DirectoriForm ADV

We also hold 7 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$124Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
Legal name
Excel Venture Management, LLC
SEC number
CRD 161756

Exits from the portfolio

Companies it backed that were later bought or listed1 in all

Catch.comBought by AppleUndisclosedJan 2013

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Excel Venture Management. A count of rooms they were both in, not a relationship either has claimed.

HLM Investment PartnersVC firm5rounds togetherHealthCare VenturesGrowth equity5rounds togetherSR OneCorporate VC5rounds togetherApple Tree PartnersVC firm4rounds togetherExcel Medical VenturesGrowth equity4rounds togetherNovartis Venture FundCorporate VC4rounds togetherRoche Venture FundCorporate VC4rounds togetherLilly VenturesCorporate VC3rounds togetherMerck Global Health Innovation FundCorporate VC3rounds togetherAscension VenturesCorporate VC2rounds togetherCB Health VenturesGrowth equity2rounds togetherCue BallVC firm2rounds together

Recently backed

The latest companies Excel Venture Management put money into.

Neosensory$10M · Jan 2019

Quick answers about Excel Venture Management

What does Excel Venture Management invest in?

Excel Venture Management invests most often at Series B and Series A (58% of the rounds on record), in sectors such as E-health, Telehealth and Connected-health.

How active is Excel Venture Management?

32 investments on record, 0 of them in the last 12 months. The most recent was in Jan 2019.

What has Excel Venture Management invested in recently?

Its most recent investments on record: Neosensory (Series A, Jan 2019).

How big are Excel Venture Management's cheques?

The median round it joins is $10M.

Does Excel Venture Management lead rounds?

Rarely, if at all: none of its 32 investments on record names it as the lead.

Where does Excel Venture Management invest?

Most of the companies it backs are in the United States (97%).

Is Excel Venture Management investing now?

No investments in the last 12 months; the latest was in Jan 2019.

Who does Excel Venture Management invest alongside?

Most often HLM Investment Partners (5 rounds together), HealthCare Ventures (5 rounds together) and SR One (5 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it